Stay updated with breaking news from Brad smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
how many does it make in a row, oliver? five records in a row? oliver: we hit the record this week so this is going on the entire week matt: fourth record. oliver: we will close five days in a row with a record. but yeah, there s a lot of stuff going on, particularly i like to look at a few things happening in the u.s. stock market. jpmorgan kicked things off with not the best earnings but they beat estimates and that is what matters. financials of almost 2%. almost a presented thanks as well specifically doing even better. thething interesting in financial services metlife had a really big move, led to the market up higher and had bullish activity, five times more on volume. doingto brazil, bogus but really well, just bovespa doing really well, just killing it there. joe: remarkable. something to look at in the government bond market, u.k. s to year, see them shooting up at 7:00 a.m. story of the day in the global macro world was the boe s decision not to cut rat ....
information for targeting islamic state and an al qaeda affiliate. a potential deal seeks to prevent an escalation in .ighting i m mark crumpton. bloomberg west is next. emily: coming up, japan s leading messaging app debuted at the new york stock exchange. details ahead on the first day at the market. plus, victory for microsoft in ireland. an appeals court said no to an attempt to access a drug suspect s e-mail. we will get more information on what the court decision means for data security here in the united states. a new set of digital eyes for the outdoors courtesy of nest. company had of hardware tells us why the new camera will change the game. first, to our lead. japan s leading messaging at its a warm welcome at the new york stock exchange with shares surging in the company s first-day day of trading after the company priced 18% above initial estimates. spoke to the cofounder and ceo and began by asking how they deal about the investor response. first of all ....
for future public offerings. plus, the infamous biotech ceo martin shkreli was back in court today. he now faces eight counts of fraud and conspiracy to commit fraud charges. he has a trial date has been set. we ll have the latest developments from the courthouse in just a few minutes. and larry kudlow has bold plans in a federal reserve restructuring, the whole thing. he says janet yellin and everyone else should be thrown out. find out who he thinks should and it s not larry. he doesn t think himself should be at the helm here, but he has some ideas about who should be. coming up. let s start with jpmorgan chase earrings beat. kayla tausche is standing by on the floor of the stock exchange. the stock has been up close to 2% all day and it is really boding well for the rest of the banks as well, having a halo effect, not only on the other big money centers that still have to report, but also on visa, after positive data on credit card spending from the bank. ....
deadly earthquake fallout in central italy. oil inventory on the way pfr our road map with elon musk s need for speed. tesla announcing new models with a longer range. the epi pen controversy at myland. details about executive pay there. today is the one-year anniversary of the 1,000 point drop in the dow. a look back at what was a dramatic session. speaking of which, jim, on that day, the vix posted its biggest one-day spike ever even as now a year later it s 40% below the 10-year average. we remember that day well. there was a lot of disorganization and a lot of fear. there were stocks trading, i remember celgene down 20 bucks. there was no news on celgene. that friday we had gotten james bull yard, an interview on sirius satellite, making a case for a rate hike while making a case for china. i think what an opportunity the market down 1,000 and rallied to be down 100 and finished down 588. turned out to be the max numb fear moment. china did grow at 6%, not 7. the ....
medical association, democratic e on ageing. they are all adding their names to the list of those concerned about the rising price of epipens. the medication that can stop life threatening allergic reactions. as the criticism grows, so does the pressure on mylan. shares fell 5% today and are down about 12% since friday me relationsh growth of epipen sales. the s the epipen only heightened today with washington ratcheting up the pressure. pharmaceutical companies that often try to portray themselves as if the inventor medication, often do real damage to by being greed di. and jacking up prices in a way that victimizes vulnerable americans. josh earnest said in response to a question about prices, that the white house isn t second guessing mylan, but that prescription drug price questions.an raise d hillary clinton weighed in, tweeting this epipens can be the difference between life and death. there s no justification in the prn 500% to more than $600 for a pack of ....